mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public

NCT ID: NCT06293508

Last Updated: 2024-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

1180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-30

Study Completion Date

2024-10-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Late-stage presentation of breast cancer cases are on the rise in Malaysia. Encouraging breast screening practices can assist in early breast cancer detection. Literature has proven that behavior interventions in the form of behavior change health communication using social messaging applications is a viable strategy and potentially effective at motivating breast cancer screening among the public. Such studies are scarce in the South East Asian region, particularly in Malaysia, which is the prime motivation for the current study,

Based on this promising prospect, a randomized controlled trial will be designed to study the effects of applying persuasive health communication materials to initiate behavior change among a group of Malaysian women. Materials are delivered in the form of a health communication program over a social messaging application to promote breast cancer screening practices, which is either a clinical breast examination, or a mammogram. The investigators hypothesize that Malaysian women who are exposed to such materials that are designed based on behavior science and behavior change principles will be nudged and hence more likely to attend breast cancer screening compared to a control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study involves a randomized controlled trial to asses the effectiveness of a health communication program using specifically designed materials using behavior science and behavior change principles. Materials were designed based on findings derived from a scoping review and interviewing Malaysian women through a series of qualitative interviews to determine the barriers and facilitators of attending breast cancer screening. The interview also investigated women's preferences for certain characteristics in a health message and health communication program that would motivate them to attend screening.

Participants in the main experimental group will be compared with a control group, and another group which undergoes a standard health communication program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Neoplasm Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

Participants do not receive any message throughout the study period.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental Arm 1

Participants in this group will receive a message on a weekly basis throughout the intervention period, which is 6 months, via WhatsApp.

Group Type EXPERIMENTAL

Standard Health Communication Intervention

Intervention Type BEHAVIORAL

Participants in this group will receive links and materials related to breast cancer screening from official sources (e.g. MOH, Non-governmental organizations (NGOs), etc.) that is already readily available and accessible by the Malaysian public. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.

Experimental Arm 2

Participants in this group will receive a message on a weekly basis throughout the intervention period, which is 6 months, via WhatsApp.

Group Type EXPERIMENTAL

Behavioural Change Health Communication Intervention

Intervention Type BEHAVIORAL

Participants receive health communication materials designed using persuasive behavioural change communication principles and behavior science to promote breast cancer screening. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Health Communication Intervention

Participants in this group will receive links and materials related to breast cancer screening from official sources (e.g. MOH, Non-governmental organizations (NGOs), etc.) that is already readily available and accessible by the Malaysian public. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.

Intervention Type BEHAVIORAL

Behavioural Change Health Communication Intervention

Participants receive health communication materials designed using persuasive behavioural change communication principles and behavior science to promote breast cancer screening. Frequency, duration, and platform of dissemination will be based on findings from Phase 1 of this study.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Malaysian women aged 40 years and above
2. Possess a smartphone with the predetermined social messaging application (derived from Phase 1 of study) installed.
3. Have not been diagnosed with cancer before.

Exclusion Criteria

1. Underwent Clinical Breast Examination in the past 12 months.
2. Mammogram screening in the past 2 years.
3. Subjects who are deemed to have cognitive impairment and unable to provide consent to the study.
Minimum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, Malaysia

OTHER_GOV

Sponsor Role collaborator

National University of Malaysia

OTHER

Sponsor Role collaborator

Institute for Health Behavioral Research, Malaysia

UNKNOWN

Sponsor Role collaborator

Clinical Research Centre, Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nicholas Hing Yee Liang

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicholas Yee Liang Hing, MSc

Role: PRINCIPAL_INVESTIGATOR

Institute for Clinical Research, National Institutes of Health, Malaysia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute for Clinical Research, National Institutes of Health, Malaysia

Shah Alam, Selangor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NMRR ID-22-02616-I2I

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breast Cancer Prevention Education
NCT01299623 COMPLETED NA
Rx for Better Breast Health
NCT02279303 COMPLETED NA